Bravecto 1400 mg (Fluralaner TABLET (CHEWABLE)) 1400 MG

Bravecto 1400 mg is a chewable tablet containing fluralaner, used for parasite control in pets. This oral medication offers long-lasting protection against fleas and ticks, ensuring your pet's comfort and health.

Strength

1400 MG

Pack Size

1/2/4

Manufacturer / TM Owner

INTERVET CANADA CORP

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Bravecto 1400 mg is primarily used for the treatment and prevention of flea and tick infestations in pets. This chewable tablet is designed to provide extended protection, making it a convenient option for pet owners. Many pet owners wonder, 'What is Bravecto used for?' It is commonly used to manage and prevent parasitic infestations, ensuring the well-being of dogs and cats.

Side Effects

Bravecto 1400 mg works by targeting the nervous system of fleas and ticks, leading to their paralysis and eventual death. Pet owners may notice a reduction in flea and tick activity within a few hours of administration. Common effects include improved pet comfort and reduced itching.

Precautions & Warnings

It is important to follow the recommended dosage and administration guidelines provided by your veterinarian. Bravecto 1400 mg should not be used on pets under 6 months of age or those with known hypersensitivity to fluralaner. Always consult with a healthcare professional before starting any new medication.

Avoid Interactions

Bravecto 1400 mg may interact with other medications, so it is important to inform your veterinarian about any other treatments your pet is receiving. Avoid administering Bravecto with other flea and tick products unless directed by a healthcare professional. Alcohol and certain other substances may affect the efficacy of Bravecto.

Frequently Asked Questions

Bravecto 1400 mg is used for the treatment and prevention of flea and tick infestations in pets, providing long-lasting protection.

Bravecto 1400 mg targets the nervous system of fleas and ticks, causing paralysis and death, which helps in managing infestations.

Bravecto 1400 mg should not be used on pets under 6 months of age. Always consult with a veterinarian before administering any medication to young pets.

Common effects include reduced flea and tick activity, improved pet comfort, and reduced itching. Always monitor your pet for any adverse reactions.

The frequency of administration depends on your pet's specific needs and the recommendations of your veterinarian. Typically, it is given every 12 weeks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.